Abstract:Major depressive disorder is one of the primary causes of disability and disease worldwide. The therapy of depression is prevalently based on monoamine reuptake blockers; consequently, investigations aimed to clarify the aetiology of depression have mostly looked at brain areas innervated by monamines and brain circuitry involved in inputs and outputs of these areas. The recent approval of esketamine as a rapid-acting antidepressant drug in treatment-resistant depression, has definitively projected glutamatergic transmission as a key constituent in the use of new drugs in antidepressant therapy. In this review we have examined the role of several brain areas: namely, the hippocampus, the medial Prefrontal Cortex (mPFC), the nucleus accumbens (NAc), the Lateral Habenula (LHb), the amygdala and the Bed Nucleus of Stria Terminalis (BNST). The reason for undertaking an in-depth review is due to their significant role in animal models of depression, which highlight their inter-connections as well as their inputs and outputs. In particular, we examined the modification of the expression and release of the brain derived neurotrophic factor (BDNF) and associated changes in dendritic density induced by chronic stress in the above areas of animal models of depression (AnMD). We also examined the effectiveness of ketamine and standard antidepressants in reversing these alterations, with the aim of identifying a brain circuit where pathological alteration might trigger the appearance of depression symptoms. Based on the role that these brain areas play in the generation of the symptoms of depression, we assumed that the mPFC, the NAc/Ventral Tegmental Area (VTA) and the hippocampus form a primary circuit of depression, where regular performance can endure resilience to stress. We have also examined how this circuit is affected by environmental challenges and how the activation of one or more areas, including amygdala, LHb or BNST can produce local detrimental effects that spread over specific circuits and generate depression symptoms. Furthermore, we also examined how, through their outputs, these three areas can negatively influence the NAc/VTA-PFC circuit directly or through the BNST, to generate anhedonia, one of the most devastating symptoms of depression.

The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Vulnerability and plasticity of monoamine neurotransmitter systems in affective and personality disorders

History and evolution of the monoamine hypothesis of depression.

Comment on: Antidepressants act by directly binding to TRKB neurotrophin receptors

The neuropharmacology of serotonin and noradrenaline in depression

Catecholamine and HPA Axis Dysfunction in Depression: Relationship with Suicidal Behavior

Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

Norepinephrine, Dopamine and Serotonin: CNS Distribution, Biosynthesis and Metabolism

Behavioral Response to Catecholamine Depletion in Individuals With Schizophrenia and Healthy Volunteers

The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited

Serotonin and beyond: therapeutics for major depression

Neuronal nitric oxide synthase and affective disorders

Serotonin is a common thread linking different classes of antidepressants

The involvement of serotonin in major depression: nescience in disguise?

Re-assessing the catecholamine hypothesis of depression: the case of melancholic depression

Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder

BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression